1980PubMedRequires access

The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.

Hasan Yazıcı, Y Tüzün, Halit Pazarlı, Başak Yalçın, Sabahattin Yurdakul, Asuman Ü. Müftüoğlu

Open publisher page 47 citations

Abstract

Forty-one of 49 (84%) patients with Behçet's disease in Turkey carried HLA-B5 (positive B5). Forty of the same 49 (82%) patients had a nonspecific skin hyperreactivity to needle prick (positive pathergy). There were no patients in whom both of these tests were negative.

About this research paper

What this paper is about

Forty-one of 49 (84%) patients with Behçet's disease in Turkey carried HLA-B5 (positive B5). Forty of the same 49 (82%) patients had a nonspecific skin hyperreactivity to needle prick (positive pathergy). There were no patients in whom both of these tests were negative.

Why it matters

OpenAlex reports 47 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Forty-one of 49 (84%) patients with Behçet's disease in Turkey carried HLA-B5 (positive B5). Forty of the same 49 (82%) patients had a nonspecific skin hyperreactivity to needle prick (positive pathergy). There were no patients in whom both of these tests were negative.

Key concepts: Pathergy, Medicine, Behcet's disease, Dermatology, Disease, Surgery, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. — Research Paper | ScholarLens